𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen–Friedenreich tumor antigen

✍ Scribed by Christian Schindlbeck; Udo Jeschke; Sandra Schulze; Uwe Karsten; Wolfgang Janni; Brigitte Rack; Harald Sommer; Klaus Friese

Publisher
Springer
Year
2005
Tongue
English
Weight
309 KB
Volume
123
Category
Article
ISSN
1432-119X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disseminated tumor cells in the bone mar
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
✍ Nicole Sänger; Katharina E. Effenberger; Sabine Riethdorf; Viviane Van Haasteren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 160 KB 👁 2 views

## Abstract Detection of disseminated tumor cells (DTCs) in bone marrow is an independent prognostic factor in primary breast cancer. Here, we conducted a proof‐of‐principle study to evaluate whether this tumor cell spread occurs already in patients with ductal carcinoma in situ (DCIS). After preop

Monitoring of disseminated tumor cells i
Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
✍ Vilde Drageset; Jahn M. Nesland; Bjorn Erikstein; Eva Skovlund; Hilde Sommer; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 1 views

## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent

Quantitative analysis of disseminated tu
Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysis
✍ Gábor Méhes; Thomas Lörch; Peter F. Ambros 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Accurate quantification of disseminated tumor cells in hematological samples is of fundamental importance in clinical oncology. However, even highly standardized protocols allow only a rough estimation of the total analyzed cell number, as sample processing may have adverse effects on the number of